{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:22:25Z","timestamp":1794057745236,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Alexandre Suerman Stipend, University Medical Centre Utrecht","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Pathophysiology of life-threatening acute metabolic decompensations (AMD) in propionic acidemia (PA) and isolated methylmalonic acidemia (MMA) is insufficiently understood. Here, we study the metabolomes of PA and MMA patients over time, to improve insight in which biochemical processes are at play during AMD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Longitudinal data from clinical chemistry analyses and metabolic assays over the life-course of 11 PA and 13 MMA patients were studied retrospectively. Direct-infusion high-resolution mass spectrometry was performed on 234 and 154 remnant dried blood spot and plasma samples of PA and MMA patients, respectively. In addition, a systematic literature search was performed on reported biomarkers. All results were integrated in an assessment of biochemical processes at play during AMD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We confirmed many of the metabolite alterations reported in literature, including increases of plasma valine and isoleucine during AMD in PA patients. We revealed that plasma leucine and phenylalanine, and urinary pyruvic acid were increased during AMD in PA patients. 3-hydroxyisovaleric acid correlated positively with plasma ammonia. We found that known diagnostic biomarkers were not significantly further increased, while intermediates of the branched-chain amino acid (BCAA) degradation pathway were significantly increased during AMD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We revealed that during AMD in PA and MMA, BCAA and BCAA intermediates accumulate, while known diagnostic biomarkers remain essentially unaltered. This implies that these acidic BCAA intermediates are responsible for metabolic acidosis. Based on this, we suggest to measure plasma 3-hydroxyisovaleric acid and urinary ketones or 3-hydroxybutyric acid for the biochemical follow-up of a patient\u2019s metabolic stability.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-020-1347-3","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T17:02:31Z","timestamp":1583514151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Understanding acute metabolic decompensation in propionic and methylmalonic acidemias: a deep metabolic phenotyping approach"],"prefix":"10.1186","volume":"15","author":[{"given":"H. A.","family":"Haijes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J. M.","family":"Jans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van der Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Verhoeven-Duif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"1347_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10545-011-9426-1","volume":"35","author":"T Zwickler","year":"2012","unstructured":"Zwickler T, Haege G, Riderer A, H\u00f6rster F, Hoffmann GF, Burgard P, K\u00f6lker S. Metabolic decompensation in methylmalonic aciduria: which biochemical parameters are discriminative? J Inherit Metab Dis. 2012;35:797\u2013806.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10545-013-9621-3","volume":"37","author":"T Zwickler","year":"2014","unstructured":"Zwickler T, Riderer A, Haege G, Hoffmann GF, K\u00f6lker S, Burgard P. Usefulness of biochemical parameters in decision-making on the start of emergency treatment in patients with propionic acidemia. J Inherit Metab Dis. 2014;37:31\u20137.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","volume":"9","author":"MR Baumgartner","year":"2014","unstructured":"Baumgartner MR, H\u00f6rster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, Huemer M, Hochuli M, Assoun M, Ballhausen D, Burlina A, Fowler B, Gr\u00fcnert SC, Gr\u00fcnewald S, Honzik T, Merinero B, P\u00e9rez-Cerd\u00e1 C, Scholl-B\u00fcrgi S, Skovby F, Wijburg F, MacDonald A, Martinelli D, Sass JO, Valayannopoulos V, Chakrapani A. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014;9:130.","journal-title":"Orphanet J Rare Dis"},{"key":"1347_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jimd.12129","volume":"42","author":"HA Haijes","year":"2019","unstructured":"Haijes HA, Jans JJM, Tas SY, van Hasselt PM, Verhoeven-Duif NM. Pathophysiology of propionic and methylmalonic acidemias. Part 1: Complications. J Inherit Metab Dis. 2019;42:730\u201344 Epub ahead of print.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/jimd.12128","volume":"42","author":"HA Haijes","year":"2019","unstructured":"Haijes HA, van Hasselt PM, Jans JJM, Verhoeven-Duif NM. Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies. J Inherit Metab Dis. 2019;42:745\u201361 Epub ahead of print.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR6","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.3390\/metabo9010012","volume":"9","author":"HA Haijes","year":"2019","unstructured":"Haijes HA, Willemsen M, van der Ham M, Gerrits J, Pras-Raves ML, Prinsen HCMT, van Hasselt PM, de Sain-van der Velden MGM, Verhoeven-Duif NM, Jans JJM. Direct infusion based metabolomics identifies metabolic disease in patients\u2019 dried blood spots and plasma. Metabolites. 2019;9:E12.","journal-title":"Metabolites"},{"key":"1347_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/nar\/gky310","volume":"46","author":"J Chong","year":"2018","unstructured":"Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, Wishart DS, Xia J. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46:486\u20134.","journal-title":"Nucleic Acids Res"},{"key":"1347_CR8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1542\/peds.27.4.522","volume":"27","author":"B Childs","year":"1961","unstructured":"Childs B, Nyhan WL, Borden M, Bard L, Cooke RE. Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. I. Pediatrics. 1961;27:522\u201338.","journal-title":"Pediatrics"},{"key":"1347_CR9","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S0140-6736(70)91216-X","volume":"1","author":"D Gompertz","year":"1970","unstructured":"Gompertz D, Storrs CN, Bau DC, Peters TJ, Hughes EA. Localisation of enzymic defect in propionicacidaemia. Lancet. 1970;1:1140\u20133.","journal-title":"Lancet"},{"key":"1347_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJM196806132782404","volume":"278","author":"LE Rosenberg","year":"1968","unstructured":"Rosenberg LE, Lillljeqvist AC, Hsia YE. Methylmalonic aciduria \u2013 an inborn error leading to metabolic acidosis, long-chain ketonuria and intermittent hyperglycinemia. N Engl J Med. 1968;278:1319\u201322.","journal-title":"N Engl J Med"},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1203\/00006450-196811000-00010","volume":"2","author":"FA Hommes","year":"1968","unstructured":"Hommes FA, Kuipers JR, Elema JD, Jansen JF, Jonxis JH. Propionicacidemia, a new inborn error of metabolism. Pediatr Res. 1968;2:519\u201324.","journal-title":"Pediatr Res"},{"key":"1347_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0022-3476(71)80354-2","volume":"78","author":"T Ando","year":"1971","unstructured":"Ando T, Rasmussen K, Nyhan WL, Donell GN, Barnes ND. Propionic acidemia in patients with ketotic hyperglycinemia. J Pediatr. 1971;78:827\u201332.","journal-title":"J Pediatr"},{"key":"1347_CR13","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/S0021-9258(19)45512-9","volume":"247","author":"T Ando","year":"1972","unstructured":"Ando T, Rasmussen K, Wright JM, Nyhan WL. Isolation and identification of methylcitrate, a major metabolic product of propionate in patients with propionic acidemia. J Biol Chem. 1972;247:2200\u20134.","journal-title":"J Biol Chem"},{"key":"1347_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0009-8981(74)90386-6","volume":"52","author":"RA Chalmers","year":"1974","unstructured":"Chalmers RA, Lawson AM, Watts RW. Studies on the urinary acidic metabolites excreted by patients with beta-methylcrotonylglycinuria, propionic acidaemia and methylmalonic acidaemia, using gas-liquid chromatography and mass spectrometry. Clin Chim Acta. 1974;52:43\u201351.","journal-title":"Clin Chim Acta"},{"key":"1347_CR15","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1073\/pnas.69.10.2807","volume":"69","author":"T Ando","year":"1972","unstructured":"Ando T, Rasmussen K, Nyhan WL, Hull D. 3-hydroxypropionate: significance of \u2013oxidation of propionate in patients with propionic acidemia and methylmalonic acidemia. Proc Natl Acad Sci U S A. 1972;69:2807\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1347_CR16","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1042\/cs0420665","volume":"42","author":"K Rasmussen","year":"1972","unstructured":"Rasmussen K, Ando T, Nyhan WL, Hull D, Cottom D, Donnell G, Wadlington W, Kilroy AW. Excretion of propionylglycine in propionic acidaemia. Clin Sci. 1972;42:665\u201371.","journal-title":"Clin Sci"},{"key":"1347_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1203\/00006450-199004000-00021","volume":"27","author":"GN Thompson","year":"1990","unstructured":"Thompson GN, Chalmers RA. Increased urinary metabolite excretion during fasting in disorders of propionate metabolism. Pediatr Res. 1990;27:413\u20136.","journal-title":"Pediatr Res"},{"key":"1347_CR18","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0022-3476(72)80551-1","volume":"81","author":"K Rasmussen","year":"1972","unstructured":"Rasmussen K, Ando T, Nyhan WL, Hull D, Cottom D, Kilroy AW, Wadlington W. Excretion of tiglylglycine in propionic acidemia. J Pediatr. 1972;81:970\u20132.","journal-title":"J Pediatr"},{"key":"1347_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.braindev.2011.07.002","volume":"34","author":"M Imen","year":"2012","unstructured":"Imen M, Hanene B, Ichraf K, Aida R, Ilhem T, Naziha K, Neziha GK. Methylmalonic acidemia and hyperglycemia: an unusual association. Brain and Development. 2012;34:113\u20134.","journal-title":"Brain and Development"},{"key":"1347_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bms.1200090102","volume":"9","author":"M Duran","year":"1982","unstructured":"Duran M, Bruinvis L, Ketting D, Kamerling JP, Wadman SK, Schutgens RB. The identification of (E)-2-methylglutaconic acid, a new isoleucine metabolite, in the urine of patients with beta-ketothiolase deficiency, propionic acidaemia and methylmalonic acidaemia. Biomed Mass Spectrom. 1982;9:1\u20135.","journal-title":"Biomed Mass Spectrom"},{"key":"1347_CR21","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1373\/clinchem.2007.089011","volume":"53","author":"WR Wikoff","year":"2007","unstructured":"Wikoff WR, Gangoiti JA, Barshop BA, Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem. 2007;53:2169\u201376.","journal-title":"Clin Chem"},{"key":"1347_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/adc.58.11.916","volume":"58","author":"CR Roe","year":"1983","unstructured":"Roe CR, Hoppel CL, Stacey TE, Chalmers RA, Tracey BM, Millington DS. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child. 1983;58:916\u201320.","journal-title":"Arch Dis Child"},{"key":"1347_CR23","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cca.2015.09.012","volume":"23","author":"S Malvagia","year":"2015","unstructured":"Malvagia S, Haynes CA, Grisotto L, Ombrone D, Funghini S, Moretti E, McGreevy KS, Biggeri A, Guerrini R, Yahyaoui R, Garg U, Seeterlin M, Chace D, De Jesus VR, la Marca G. Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias. Clin Chim Acta. 2015;23:342\u20138.","journal-title":"Clin Chim Acta"},{"key":"1347_CR24","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1042\/bj1261035","volume":"126","author":"WL Nyhan","year":"1972","unstructured":"Nyhan WL, Ando T, Rasmussen K, Wadlington W, Kilroy AW, Cottom D, Hull D. Tiglicaciduria in propionicacidaemia. Biochem J. 1972;126:1035\u20137.","journal-title":"Biochem J"},{"key":"1347_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/adc.42.225.492","volume":"42","author":"VG Oberholzer","year":"1967","unstructured":"Oberholzer VG, Levin B, Burgess EA, Young WF. Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child. 1967;42:492\u2013504.","journal-title":"Arch Dis Child"},{"key":"1347_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1651-2227.1976.tb04417.x","volume":"65","author":"H van den Berg","year":"1976","unstructured":"van den Berg H, Boelkens MT, Hommes FA. A case of methylmalonic and propionic acidemia due to methylmalonyl-CoA carbonylmutase apoenzyme deficiency. Acta Paediatr Scand. 1976;65:113\u20138.","journal-title":"Acta Paediatr Scand"},{"key":"1347_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/rcm.2905","volume":"21","author":"Y Maeda","year":"2007","unstructured":"Maeda Y, Ito T, Suzuki A, Kurono Y, Ueta A, Yokoi K, Sumi S, Togari H, Sugiyama N. Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography\/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom. 2007;21:799\u2013806.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1347_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0009-8981(82)90118-8","volume":"123","author":"T Kuhara","year":"1982","unstructured":"Kuhara T, Shinka T, Matsuo M, Matsumoto I. Increased excretion of lactate, glutarate, 3-hydroxyisovalerate and 3-methylglutaconate during clinical episodes of propionic acidemia. Clin Chim Acta. 1982;123:101\u20139.","journal-title":"Clin Chim Acta"},{"key":"1347_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF02312526","volume":"3","author":"S K\u00f8lvraa","year":"1980","unstructured":"K\u00f8lvraa S, Gregersen N, Christensen E, Rasmussen K. Excretion pattern of branched-chain amino acid metabolites during the course of acute infections in a patient with methylmalonic acidaemia. J Inherit Metab Dis. 1980;3:63\u20136.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ymgme.2005.11.016","volume":"88","author":"HR Filipowicz","year":"2006","unstructured":"Filipowicz HR, Ernst SL, Ashurst CL, Pasquali M, Longo N. Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab. 2006;88:123\u201330.","journal-title":"Mol Genet Metab"},{"key":"1347_CR31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10545-014-9706-7","volume":"37","author":"MG de Sain-van der Velden","year":"2014","unstructured":"de Sain-van der Velden MG, van der Ham M, Verhoeven-Duif NM, Visser G, van Hasselt PM. Comment on Zwickler et al.: usefulness of biochemical parameters in decision-making on the start of emergency treatment in patients with propionic acidemia. J Inherit Metab Dis. 2014;37:651\u20132.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR32","doi-asserted-by":"publisher","first-page":"207S","DOI":"10.1093\/jn\/136.1.207S","volume":"136","author":"JT Brosnan","year":"2006","unstructured":"Brosnan JT, Brosnan ME. Branched-chain amino acids: enzyme and substrate regulation. J Nutr. 2006;136:207S\u201311S.","journal-title":"J Nutr"},{"key":"1347_CR33","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI109614","volume":"64","author":"FX Coude","year":"1979","unstructured":"Coude FX, Sweetman L, Nyhan WL. Inhibition by propionyl-coenzyme a of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. J Clin Invest. 1979;64:1544\u201351.","journal-title":"J Clin Invest"},{"key":"1347_CR34","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00726-009-0356-2","volume":"38","author":"S Scholl-B\u00fcrgi","year":"2010","unstructured":"Scholl-B\u00fcrgi S, Sass JO, Heinz-Erian P, Amann E, Haberlandt E, Albrecht U, Ertl C, Sigl SB, Lagler F, Rostasy K, Karall D. Changes in plasma amino acid concentrations with increasing age in patients with propionic acidemia. Amino Acids. 2010;38:1473\u201381.","journal-title":"Amino Acids"},{"key":"1347_CR35","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/jimd.12100","volume":"42","author":"J H\u00e4berle","year":"2019","unstructured":"H\u00e4berle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G, Santer R, Skouma A, Servais A, Tal G, Rubio V, Huemer M, Dionisi-Vici C. Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision. J Inherit Metab Dis. 2019;42:1192\u2013230 Epub ahead of print.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s004310050010","volume":"159","author":"W Sperl","year":"2000","unstructured":"Sperl W, Murr C, Skladal D, Sass JO, Suormala T, Baumgartner R, Wendel U. Odd-numbered long-chain fatty acids in propionic acidemia. Eur J Pediatr. 2000;159:54\u20138.","journal-title":"Eur J Pediatr"},{"key":"1347_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/BF02436003","volume":"18","author":"U Wendel","year":"1995","unstructured":"Wendel U, Eissler A, Sperl W, Schadewaldt P. On the differences between urinary metabolite excretion and odd-numbered fatty acid production in propionic and methylmalonic acidaemias. J Inherit Metab Dis. 1995;18:584\u201391.","journal-title":"J Inherit Metab Dis"},{"key":"1347_CR38","first-page":"556","volume":"22","author":"F Yuan","year":"2001","unstructured":"Yuan F, Wang TY, Xu LX, Sun YL, Luo L, Qu BQ. Neurotoxic effect of high dose of L-(+)-2-amino-3-phosphonopropionic acid in rats after intracaudatal injection. Acta Pharmacol Sin. 2001;22:556\u201360.","journal-title":"Acta Pharmacol Sin"},{"key":"1347_CR39","first-page":"222","volume":"38","author":"DD Schoepp","year":"1990","unstructured":"Schoepp DD, Johnson BG, Smith EC, McQuaid LA. Stereoselectivity and mode of inhibition of phosphoinositide-coupled excitatory amino acid receptors by 2-amino-3-phosphonopropionic acid. Mol Pharm. 1990;38:222\u20138.","journal-title":"Mol Pharm"},{"key":"1347_CR40","first-page":"1057","volume":"47","author":"A Ambrosini","year":"1990","unstructured":"Ambrosini A, Bresciani L, Fracchia S, Brunello N, Racagni G. Metabotrophic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol Pharm. 1990;47:1057\u201364.","journal-title":"Mol Pharm"},{"key":"1347_CR41","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.neuroscience.2007.03.022","volume":"146","author":"CRM Malfatti","year":"2007","unstructured":"Malfatti CRM, Perry MLS, Schweigert ID, Muller AP, Paguetti L, Rigo FK, Fighera MR, Garrido-Sanabria ER, Mello CF. Convulsions induced by methylmalonic acid are associated with glutamic acid decarboxylase inhibition in rats: a role for GABA in the seizures presented by methylmalonic acidemia patients? Neuroscience. 2007;146:1879\u201387.","journal-title":"Neuroscience"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-1347-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-1347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:33:21Z","timestamp":1695886401000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-1347-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-1347-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee of the University Medical Center Utrecht (17\u2013490\/C) and with the Helsinki Declaration of 1975, as revised in 2000. Written informed consent was obtained from all included patients or their legal guardians.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors state that they have no competing interests to declare. None of the authors accepted any reimbursements, fees or funds from any organization that may in any way gain or lose financially from the results of this study. The authors have not been employed by such an organization. The authors do not have any other competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}